MIM
AXDX

Monashee Investment Management’s Accelerate Diagnostics AXDX Stock Holding History

Monashee Investment Management’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-1,146
Closed -$246K – 41
2015
Q4 		$246K Buy
+1,146
New +$209K 0.49% 24

Other funds holding AXDX

OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
MGM
Miura Global Management New York $43.8M AUM 53.8% 1-Year Est. Return
JMPWA
JP Morgan Private Wealth Advisors San Francisco, California $35B AUM 24.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Monashee Investment Management's AXDX Position: Q1 2016 in Review

Monashee Investment Management sold out of Accelerate Diagnostics (AXDX) in Q1 2016, closing a stake of 1,146 shares — an estimated $246K sold.

Monashee Investment Management first reported a position in AXDX in Q4 2015 and held it in 1 quarter. The position peaked at $246K in Q4 2015. 92 funds tracked by Wall St. Rank hold AXDX as of Q1 2016.

  • Monashee Investment Management reported no remaining Accelerate Diagnostics position as of Q1 2016 after selling out during the quarter.
  • Monashee Investment Management sold 1,146 Accelerate Diagnostics shares in Q1 2016, an estimated $246K.
  • Monashee Investment Management first reported a position in Accelerate Diagnostics in Q4 2015 and held it in 1 quarter.
  • Monashee Investment Management's Accelerate Diagnostics position peaked at $246K in Q4 2015.
  • 92 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q1 2016.

Based on Monashee Investment Management's 13F filing for Q1 2016, filed 13 May 2016.